Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Schizophrenia

Free Subscription Articles published in J Clin Psychiatry Retrieve available abstracts of 189 articles: HTML format

Single Articles

May 2008
1. ANGLIN DM , Malaspina D
   Ethnicity Effects on Clinical Diagnoses Compared to Best-Estimate Research Diagnoses in Patients With Psychosis: A Retrospective Medical Chart Review.
   J Clin Psychiatry. 2008;:e1-e5.
   PubMed     Related articles    Abstract available
   
   
   
2. MELTZER HY , Bobo WV, Nuamah IF, Lane R, et al
   Efficacy and Tolerability of Oral Paliperidone Extended-Release Tablets in the Treatment of Acute Schizophrenia: Pooled Data From Three 6-Week, Placebo-Controlled Studies.
   J Clin Psychiatry. 2008;:e1-e13.
   PubMed     Related articles    Abstract available
   
   
   April 2008
3. LAURIELLO J , Lambert T, Andersen S, Lin D, et al
   An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia.
   J Clin Psychiatry. 2008;:e1-e10.
   PubMed     Related articles    Abstract available
   
   
   
4. BLONDE L , Kan HJ, Gutterman EM, L'italien GJ, et al
   Predicted Risk of Diabetes and Coronary Heart Disease in Patients With Schizophrenia: Aripiprazole Versus Standard of Care.
   J Clin Psychiatry. 2008;:e1-e8.
   PubMed     Related articles    Abstract available
   
   
   
5. KANE JM
   Relapse prevention in patients with schizophrenia.
   J Clin Psychiatry. 2008;69:e11.
   PubMed     Related articles    Abstract available
   
   
   
6. CORRELL CU
   Antipsychotic polypharmacy, part 1: Shotgun approach or targeted cotreatment?
   J Clin Psychiatry. 2008;69:674-5.
   PubMed     Related articles   
   
   
   
7. CORRELL CU , Kane JM, Manu P
   Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?
   J Clin Psychiatry. 2008;69:578-83.
   PubMed     Related articles    Abstract available
   
   
   
8. FLEISCHHACKER WW , Cetkovich-Bakmas M, De Hert M, Hennekens CH, et al
   Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges.
   J Clin Psychiatry. 2008;69:514-9.
   PubMed     Related articles    Abstract available
   
   
   
9. PASCUAL JC , Soler J, Puigdemont D, Perez-Egea R, et al
   Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study.
   J Clin Psychiatry. 2008;69:603-8.
   PubMed     Related articles    Abstract available
   
   
   March 2008
10. CHANG JS , Ahn YM, Park HJ, Lee KY, et al
    Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    J Clin Psychiatry. 2008;:e1-e12.
    PubMed     Related articles    Abstract available
    
    
    
11. GLICK ID , Siris SG, Davis JM
    Treating schizophrenia with comorbid depressive or demoralization symptoms.
    J Clin Psychiatry. 2008;69:501.
    PubMed     Related articles   
    
    
    
12. VILLERO S , Fraguas D
    Gender imbalance in clinical trials in schizophrenia.
    J Clin Psychiatry. 2008;69:498-9.
    PubMed     Related articles   
    
    
    
13. 
    Clinical insights into pharmacogenetics and schizophrenia, part 1.
    J Clin Psychiatry. 2008;69:487-94.
    PubMed     Related articles   
    
    
    
14. TARIOT PN
    Psychosis and agitation in dementia: should general psychiatrists care?
    J Clin Psychiatry. 2008;69:339-40.
    PubMed     Related articles   
    
    
    
15. ANGLIN DM , Malaspina D
    Racial and ethnic effects on psychotic psychiatric diagnostic changes from admission to discharge: a retrospective chart review.
    J Clin Psychiatry. 2008;69:464-9.
    PubMed     Related articles    Abstract available
    
    
    February 2008
16. LEE SJ , Choi EJ, Kwon JS
    A Naturalistic Multicenter Trial of a 12-Week Weight Management Program for Overweight and Obese Patients With Schizophrenia or Schizoaffective Disorder.
    J Clin Psychiatry. 2008;:e1-e8.
    PubMed     Related articles    Abstract available
    
    
    
17. WILCOCK GK , Ballard CG, Cooper JA, Loft H, et al
    Memantine for Agitation/Aggression and Psychosis in Moderately Severe to Severe Alzheimer's Disease: A Pooled Analysis of 3 Studies.
    J Clin Psychiatry. 2008;:e1-e8.
    PubMed     Related articles    Abstract available
    
    
    
18. KISHIMOTO T , Watanabe K, Shimada N, Makita K, et al
    Antipsychotic-Induced Hyperprolactinemia Inhibits the Hypothalamo-Pituitary-Gonadal Axis and Reduces Bone Mineral Density in Male Patients With Schizophrenia.
    J Clin Psychiatry. 2008;:e1-e7.
    PubMed     Related articles    Abstract available
    
    
    
19. MATHIAS S , Lubman DI, Hides L
    Substance-Induced Psychosis: A Diagnostic Conundrum.
    J Clin Psychiatry. 2008;:e1-e10.
    PubMed     Related articles    Abstract available
    
    
    
20. VAN WINKEL R , De Hert M, Wampers M, Van Eyck D, et al
    Major Changes in Glucose Metabolism, Including New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective Disorder.
    J Clin Psychiatry. 2008;:e1-e8.
    PubMed     Related articles    Abstract available
    
    
    
21. PREDA A
    Shared decision making in schizophrenia treatment.
    J Clin Psychiatry. 2008;69:326.
    PubMed     Related articles   
    
    
    
22. ROTH BL
    High-dose olanzapine for treatment-resistant schizophrenia.
    J Clin Psychiatry. 2008;69:176-7.
    PubMed     Related articles   
    
    
    
23. LEO R , Razzini C, Di Lorenzo G, Bianchi F, et al
    Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol.
    J Clin Psychiatry. 2008;69:327-8.
    PubMed     Related articles   
    
    
    
24. TAYLOR M , Shajahan P, Lawrie SM
    Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
    J Clin Psychiatry. 2008;69:240-5.
    PubMed     Related articles    Abstract available
    
    
    
25. MORRATO EH , Newcomer JW, Allen RR, Valuck RJ, et al
    Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data.
    J Clin Psychiatry. 2008;69:316-22.
    PubMed     Related articles    Abstract available
    
    
    January 2008
26. MELTZER HY , Bobo WV, Roy A, Jayathilake K, et al
    A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia.
    J Clin Psychiatry. 2008;:e1-e12.
    PubMed     Related articles    Abstract available
    
    
    
27. MARTINEZ-ARAN A , Torrent C, Tabares-Seisdedos R, Salamero M, et al
    Neurocognitive Impairment in Bipolar Patients With and Without History of Psychosis.
    J Clin Psychiatry. 2008;:e1-e7.
    PubMed     Related articles    Abstract available
    
    
    
28. GAO K , Ganocy SJ, Gajwani P, Muzina DJ, et al
    A Review of Sensitivity and Tolerability of Antipsychotics in Patients With Bipolar Disorder or Schizophrenia: Focus on Somnolence.
    J Clin Psychiatry. 2008;:e1-e8.
    PubMed     Related articles    Abstract available
    
    
    
29. MITSONIS CI , Mitropoulos PA, Dimopoulos NP, Kararizou EG, et al
    Vardenafil in the Treatment of Erectile Dysfunction in Outpatients With Chronic Schizophrenia: A Flexible-Dose, Open-Label Study.
    J Clin Psychiatry. 2008;:e1-e7.
    PubMed     Related articles    Abstract available
    
    
    
30. MURPHY BP
    Inconclusive evidence for the efficacy of olanzapine in the treatment of negative symptoms in schizophrenia.
    J Clin Psychiatry. 2008;69:164.
    PubMed     Related articles   
    
    
    
31. SILVER H
    Selective serotonin reuptake inhibitor add-on therapy for the negative symptoms of schizophrenia.
    J Clin Psychiatry. 2008;69:163-4.
    PubMed     Related articles   
    
    
    
32. PERKINS DO , Gu H, Weiden PJ, McEvoy JP, et al
    Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.
    J Clin Psychiatry. 2008;69:106-13.
    PubMed     Related articles    Abstract available
    
    
    
33. HUDSON TJ , Owen RR, Thrush CR, Armitage TL, et al
    Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.
    J Clin Psychiatry. 2008;69:74-80.
    PubMed     Related articles    Abstract available
    
    
    
34. LAW MR , Soumerai SB, Ross-Degnan D, Adams AS, et al
    A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia.
    J Clin Psychiatry. 2008;69:47-53.
    PubMed     Related articles    Abstract available
    
    
    
35. LIN YC , Chen HZ, Chang TJ, Lane HY, et al
    Hypokalemia following rapid titration of quetiapine treatment.
    J Clin Psychiatry. 2008;69:165-6.
    PubMed     Related articles   
    
    
    
36. STROM BL , Faich GA, Reynolds RF, Eng SM, et al
    The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.
    J Clin Psychiatry. 2008;69:114-21.
    PubMed     Related articles    Abstract available
    
    
    
37. MAMO DC , Uchida H, Vitcu I, Barsoum P, et al
    Quetiapine extended-release versus immediate-release formulation: a positron emission tomography study.
    J Clin Psychiatry. 2008;69:81-6.
    PubMed     Related articles    Abstract available
    
    
    
38. MANN JJ , Ellis SP, Waternaux CM, Liu X, et al
    Classification trees distinguish suicide attempters in major psychiatric disorders: a model of clinical decision making.
    J Clin Psychiatry. 2008;69:23-31.
    PubMed     Related articles    Abstract available
    
    
    December 2007
39. PERKINS DO , Gu H, Weiden PJ, McEvoy JP, et al
    Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: A Randomized, Double-Blind, Flexible-Dose, Multicenter Study.
    J Clin Psychiatry. 2007;:e1-e8.
    PubMed     Related articles    Abstract available
    
    
    
40. RAO NP , Venkatasubramanian G, Gangadhar BN
    Treatment of cognitive deficits in schizophrenia with atomoxetine: a case report.
    J Clin Psychiatry. 2007;68:1988-9.
    PubMed     Related articles   
    
    
    
41. COMPTON MT , Whicker NE, Hochman KM
    Alcohol and cannabis use in Urban, African American, first-episode schizophrenia-spectrum patients: associations with positive and negative symptoms.
    J Clin Psychiatry. 2007;68:1939-45.
    PubMed     Related articles    Abstract available
    
    
    
42. MILLER DEL D , Eudicone JM, Pikalov A, Kim E, et al
    Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    J Clin Psychiatry. 2007;68:1901-6.
    PubMed     Related articles    Abstract available
    
    
    
43. BERGER GE , Proffitt TM, McConchie M, Yuen H, et al
    Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.
    J Clin Psychiatry. 2007;68:1867-75.
    PubMed     Related articles    Abstract available
    
    
    
44. MEI BAI Y , Chen JY, Yang WS, Chi YC, et al
    Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia.
    J Clin Psychiatry. 2007;68:1834-9.
    PubMed     Related articles    Abstract available
    
    
    
45. KHAN A , Schwartz K, Stern C, Redding N, et al
    Mortality risk in patients with schizophrenia participating in premarketing atypical antipsychotic clinical trials.
    J Clin Psychiatry. 2007;68:1828-33.
    PubMed     Related articles    Abstract available
    
    
    
46. CITROME L
    Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety.
    J Clin Psychiatry. 2007;68:1876-85.
    PubMed     Related articles    Abstract available
    
    
    November 2007
47. SADDICHHA S , Manjunatha N, Ameen S, Akhtar S, et al
    Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study.
    J Clin Psychiatry. 2007;68:1793-8.
    PubMed     Related articles    Abstract available
    
    
    
48. GAEBEL W , Riesbeck M, Wolwer W, Klimke A, et al
    Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German research network on schizophrenia.
    J Clin Psychiatry. 2007;68:1763-74.
    PubMed     Related articles    Abstract available
    
    
    
49. MOORE TA , Buchanan RW, Buckley PF, Chiles JA, et al
    The Texas medication algorithm project antipsychotic algorithm for schizophrenia: 2006 update.
    J Clin Psychiatry. 2007;68:1751-62.
    PubMed     Related articles    Abstract available
    
    
    
50. PEREZ-IGLESIAS R , Crespo-Facorro B, Amado JA, Garcia-Unzueta MT, et al
    A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    J Clin Psychiatry. 2007;68:1733-40.
    PubMed     Related articles    Abstract available
    
    
    
51. BUSHE CJ , Leonard BE
    Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.
    J Clin Psychiatry. 2007;68:1682-90.
    PubMed     Related articles    Abstract available
    
    
    
52. MUNK LAURSEN T , Munk-Olsen T, Nordentoft M, Bo Mortensen P, et al
    A comparison of selected risk factors for unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia from a danish population-based cohort.
    J Clin Psychiatry. 2007;68:1673-81.
    PubMed     Related articles    Abstract available
    
    
    
53. HETTEMA JM , Ross DE
    A case of aripiprazole-related tardive akathisia and its treatment with ropinirole.
    J Clin Psychiatry. 2007;68:1814-5.
    PubMed     Related articles   
    
    
    
54. ROSENHECK RA
    Aripiprazole and perphenazine: no difference.
    J Clin Psychiatry. 2007;68:1812-3.
    PubMed     Related articles   
    
    
    
55. KANE JM
    Teaching and practicing psychopharmacology.
    J Clin Psychiatry. 2007;68:1807-8.
    PubMed     Related articles   
    
    
    
56. 
    The roadmap for antipsychotic psychopharmacology: an overview.
    J Clin Psychiatry. 2007;68:1799-806.
    PubMed     Related articles   
    
    
    
57. LERNER V , Miodownik C, Kaptsan A, Bersudsky Y, et al
    Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study.
    J Clin Psychiatry. 2007;68:1648-54.
    PubMed     Related articles    Abstract available
    
    
    October 2007
58. LIN CH , Chou LS, Lin CH, Hsu CY, et al
    Early Prediction of Clinical Response in Schizophrenia Patients Receiving the Atypical Antipsychotic Zotepine.
    J Clin Psychiatry. 2007;68:1522-1527.
    PubMed     Related articles    Abstract available
    
    
    
59. L'ITALIEN GJ , Casey DE, Kan HJ, Carson WH, et al
    Comparison of Metabolic Syndrome Incidence Among Schizophrenia Patients Treated With Aripiprazole Versus Olanzapine or Placebo.
    J Clin Psychiatry. 2007;68:1510-1516.
    PubMed     Related articles    Abstract available
    
    
    
60. POTKIN SG , Cohen M, Panagides J
    Efficacy and Tolerability of Asenapine in Acute Schizophrenia: A Placebo- and Risperidone-Controlled Trial.
    J Clin Psychiatry. 2007;68:1492-1500.
    PubMed     Related articles    Abstract available
    
    
    
61. ROSA MO , Gattaz WF, Rosa MA, Rumi DO, et al
    Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine.
    J Clin Psychiatry. 2007;68:1528-32.
    PubMed     Related articles    Abstract available
    
    
    
62. HAUPT DW , Kane JM
    Metabolic risks and effects of atypical antipsychotic treatment.
    J Clin Psychiatry. 2007;68:e24.
    PubMed     Related articles    Abstract available
    
    
    September 2007
63. KAPUSTA ND , Mossaheb N, Barnas C, Fischer P, et al
    Aripiprazole-Induced Psychosis: A Case Report of Reexposure by Stepwise Up-Titration.
    J Clin Psychiatry. 2007;68:1445-1446.
    PubMed     Related articles    Abstract available
    
    
    
64. SIM K , Chan YH, Chong SA, Siris SG, et al
    A 24-Month Prospective Outcome Study of First-Episode Schizophrenia and Schizoaffective Disorder Within an Early Psychosis Intervention Program.
    J Clin Psychiatry. 2007;68:1368-1376.
    PubMed     Related articles    Abstract available
    
    
    
65. XU MQ , Xing QH, Zheng YL, Li S, et al
    Association of AKT1 Gene Polymorphisms With Risk of Schizophrenia and With Response to Antipsychotics in the Chinese Population.
    J Clin Psychiatry. 2007;68:1358-1367.
    PubMed     Related articles    Abstract available
    
    
    
66. LOEBEL AD , Khanna S, Rajadhyaksha S, Siu CO, et al
    Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study.
    J Clin Psychiatry. 2007;68:1333-1338.
    PubMed     Related articles    Abstract available
    
    
    
67. HARVEY PD
    Managing Cognitive Deficits and Functioning in Patients With Schizophrenia.
    J Clin Psychiatry. 2007;68:e21.
    PubMed     Related articles    Abstract available
    
    
    August 2007
68. COHEN D
    Applicability of the Oral Glucose Tolerance Test in Assessing Prevalence and Incidence of Diabetes Mellitus in Schizophrenia.
    J Clin Psychiatry. 2007;68:1307-1308.
    PubMed     Related articles    Abstract available
    
    
    
69. DUNAYEVICH E , Ascher-Svanum H, Zhao F, Jacobson JG, et al
    Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder.
    J Clin Psychiatry. 2007;68:1163-1171.
    PubMed     Related articles    Abstract available
    
    
    
70. GAILLARD R , Hemras A, Habert MO, Baup N, et al
    Cognitive facilitation and behavioral disinhibition with benzodiazepine: a case report.
    J Clin Psychiatry. 2007;68:1305-6.
    PubMed     Related articles   
    
    
    
71. BAI YM , Ting Chen T, Chen JY, Chang WH, et al
    Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study.
    J Clin Psychiatry. 2007;68:1218-25.
    PubMed     Related articles    Abstract available
    
    
    July 2007
72. AICHHORN W , Stelzig-Schoeler R, Geretsegger C, Stuppaeck C, et al
    Bright light therapy for negative symptoms in schizophrenia: a pilot study.
    J Clin Psychiatry. 2007;68:1146.
    PubMed     Related articles   
    
    
    
73. SUVISAARI JM , Saarni SI, Perala J, Suvisaari JV, et al
    Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.
    J Clin Psychiatry. 2007;68:1045-55.
    PubMed     Related articles    Abstract available
    
    
    
74. LIBOV I , Miodownik C, Bersudsky Y, Dwolatzky T, et al
    Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
    J Clin Psychiatry. 2007;68:1031-7.
    PubMed     Related articles    Abstract available
    
    
    
75. HAMANN J , Cohen R, Leucht S, Busch R, et al
    Shared decision making and long-term outcome in schizophrenia treatment.
    J Clin Psychiatry. 2007;68:992-7.
    PubMed     Related articles    Abstract available
    
    
    
76. KORTNER K , Neuhaus AH, Schurer F, Dettling M, et al
    Eosinophilia indicating subclinical clozapine-induced pericarditis.
    J Clin Psychiatry. 2007;68:1147-8.
    PubMed     Related articles   
    
    
    
77. ATKINSON JM , Douglas-Hall P, Fischetti C, Sparshatt A, et al
    Outcome following clozapine discontinuation: a retrospective analysis.
    J Clin Psychiatry. 2007;68:1027-30.
    PubMed     Related articles    Abstract available
    
    
    
78. GOFF DC , Newcomer JW
    Integrating general health care in private community psychiatry practice.
    J Clin Psychiatry. 2007;68:e19.
    PubMed     Related articles    Abstract available
    
    
    June 2007
79. SALZMAN C , Rosenberg J, Feldman JJ
    Schizophrenia symptoms remain stable during decreases from 2 antipsychotics to aripiprazole.
    J Clin Psychiatry. 2007;68:970.
    PubMed     Related articles   
    
    
    
80. BIRKENAES AB , Opjordsmoen S, Brunborg C, Engh JA, et al
    The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study.
    J Clin Psychiatry. 2007;68:917-23.
    PubMed     Related articles    Abstract available
    
    
    
81. LAURSEN TM , Munk-Olsen T, Nordentoft M, Mortensen PB, et al
    Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia.
    J Clin Psychiatry. 2007;68:899-907.
    PubMed     Related articles    Abstract available
    
    
    
82. KAPTSAN A , Odessky A, Osher Y, Levine J, et al
    Lack of efficacy of 5 grams daily of creatine in schizophrenia: a randomized, double-blind, placebo-controlled trial.
    J Clin Psychiatry. 2007;68:881-4.
    PubMed     Related articles    Abstract available
    
    
    
83. BAUML J , Pitschel-Walz G, Volz A, Engel RR, et al
    Psychoeducation in schizophrenia: 7-year follow-up concerning rehospitalization and days in hospital in the Munich Psychosis Information Project Study.
    J Clin Psychiatry. 2007;68:854-61.
    PubMed     Related articles    Abstract available
    
    
    
84. KAHN RS , Schulz SC, Palazov VD, Reyes EB, et al
    Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.
    J Clin Psychiatry. 2007;68:832-42.
    PubMed     Related articles    Abstract available
    
    
    
85. COOPER D , Moisan J, Gregoire JP
    Adherence to atypical antipsychotic treatment among newly treated patients: a population-based study in schizophrenia.
    J Clin Psychiatry. 2007;68:818-25.
    PubMed     Related articles    Abstract available
    
    
    
86. GANGULI R , Vreeland B, Newcomer JW
    Monitoring and managing weight gain in the mentally ill.
    J Clin Psychiatry. 2007;68:e14.
    PubMed     Related articles   
    
    
    May 2007
87. ARRANZ B , San L
    What do we know about insulin resistance and glucose metabolism in patients with schizophrenia treated with antipsychotics?
    J Clin Psychiatry. 2007;68:800-1.
    PubMed     Related articles   
    
    
    
88. AHUJA N , Lloyd AJ
    Aripiprazole and worsening of psychosis: a case report.
    J Clin Psychiatry. 2007;68:805-6.
    PubMed     Related articles   
    
    
    
89. KARAGIANIS J , Hoffmann VP, Stauffer VL, Treuer T, et al
    What do we know about insulin resistance and glucose metabolism in patients with schizophrenia treated with antipsychotics?
    J Clin Psychiatry. 2007;68:799-800.
    PubMed     Related articles   
    
    
    
90. WADE D , Harrigan S, McGorry PD, Burgess PM, et al
    Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis.
    J Clin Psychiatry. 2007;68:767-74.
    PubMed     Related articles    Abstract available
    
    
    
91. ZHANG XY , Tan YL, Zhou DF, Cao LY, et al
    Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia.
    J Clin Psychiatry. 2007;68:754-60.
    PubMed     Related articles    Abstract available
    
    
    
92. GRANHOLM E , McQuaid JR, McClure FS, Link PC, et al
    Randomized controlled trial of cognitive behavioral social skills training for older people with schizophrenia: 12-month follow-up.
    J Clin Psychiatry. 2007;68:730-7.
    PubMed     Related articles    Abstract available
    
    
    
93. PIERRE JM , Peloian JH, Wirshing DA, Wirshing WC, et al
    A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia.
    J Clin Psychiatry. 2007;68:705-10.
    PubMed     Related articles    Abstract available
    
    
    
94. PALMER BW , Dunn LB, Depp CA, Eyler LT, et al
    Decisional capacity to consent to research among patients with bipolar disorder: comparison with schizophrenia patients and healthy subjects.
    J Clin Psychiatry. 2007;68:689-96.
    PubMed     Related articles    Abstract available
    
    
    
95. MARDER SR , West B, Lau GS, Pultz JA, et al
    Aripiprazole effects in patients with acute schizophrenia experiencing higher or lower agitation: a post hoc analysis of 4 randomized, placebo-controlled clinical trials.
    J Clin Psychiatry. 2007;68:662-8.
    PubMed     Related articles    Abstract available
    
    
    
96. WUNDERINK L , Nienhuis FJ, Sytema S, Slooff CJ, et al
    Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
    J Clin Psychiatry. 2007;68:654-61.
    PubMed     Related articles    Abstract available
    
    
    
97. HENNEKENS CH , Newcomer JW
    Series introduction and cardiovascular disease in patients with schizophrenia.
    J Clin Psychiatry. 2007;68:e12.
    PubMed     Related articles   
    
    
    
98. HUANG CL , Su KP, Hsu HB, Pariante CM, et al
    A pilot observational crossover study of QTc interval changes associated with switching between olanzapine and risperidone.
    J Clin Psychiatry. 2007;68:803-5.
    PubMed     Related articles   
    
    
    
99. YAMAMOTO K , Fukuda M, Nogawa A, Takahashi E, et al
    Decreased lipoprotein lipase as a risk factor for atypical neuroleptic-induced hypertriglyceridemia.
    J Clin Psychiatry. 2007;68:802.
    PubMed     Related articles   
    
    
    
100. WIEDEN PJ , Newcomer JW
     Evidence of switching antipsychotic therapy to improve metabolic disturbances.
     J Clin Psychiatry. 2007;68:e13.
     PubMed     Related articles   
     
     
     April 2007
101. SEPEHRY AA , Potvin S, Elie R, Stip E, et al
     Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis.
     J Clin Psychiatry. 2007;68:604-10.
     PubMed     Related articles    Abstract available
     
     
     
102. BRECHER M , Leong RW, Stening G, Osterling-Koskinen L, et al
     Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia.
     J Clin Psychiatry. 2007;68:597-603.
     PubMed     Related articles    Abstract available
     
     
     
103. MORKEN G , Grawe RW, Widen JH
     Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia.
     J Clin Psychiatry. 2007;68:566-71.
     PubMed     Related articles    Abstract available
     
     
     
104. CORNBLATT BA , Lencz T, Smith CW, Olsen R, et al
     Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.
     J Clin Psychiatry. 2007;68:546-57.
     PubMed     Related articles    Abstract available
     
     
     
105. MAHENDRAN R , Liew E, Subramaniam M
     De novo emergence of obsessive-compulsive symptoms with atypical antipsychotics in asian patients with schizophrenia or schizoaffective disorder: a retrospective, cross-sectional study.
     J Clin Psychiatry. 2007;68:542-5.
     PubMed     Related articles    Abstract available
     
     
     
106. HENDERSON DC , Cagliero E, Copeland PM, Louie PM, et al
     Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.
     J Clin Psychiatry. 2007;68:533-41.
     PubMed     Related articles    Abstract available
     
     
     March 2007
107. 
     New developments in the treatment of schizophrenia.
     J Clin Psychiatry. 2007;68:463-78.
     PubMed     Related articles   
     
     
     
108. ALEMAN A , Sommer IE, Kahn RS
     Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis.
     J Clin Psychiatry. 2007;68:416-21.
     PubMed     Related articles    Abstract available
     
     
     
109. PAE CU , Kim JJ, Lee CU, Lee SJ, et al
     Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial.
     J Clin Psychiatry. 2007;68:399-405.
     PubMed     Related articles    Abstract available
     
     
     
110. LINDENMAYER JP , Khan A, Iskander A, Abad MT, et al
     A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
     J Clin Psychiatry. 2007;68:368-79.
     PubMed     Related articles    Abstract available
     
     
     
111. HOWES OD , Wheeler MJ, Pilowsky LS, Landau S, et al
     Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder.
     J Clin Psychiatry. 2007;68:361-7.
     PubMed     Related articles    Abstract available
     
     
     
112. LEUCHT S , Busch R, Kissling W, Kane JM, et al
     Early prediction of antipsychotic nonresponse among patients with schizophrenia.
     J Clin Psychiatry. 2007;68:352-60.
     PubMed     Related articles    Abstract available
     
     
     
113. CAROFF SN , Walker P, Campbell C, Lorry A, et al
     Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
     J Clin Psychiatry. 2007;68:410-5.
     PubMed     Related articles    Abstract available
     
     
     
114. SPURLING RD , Lamberti JS, Olsen D, Tu X, et al
     Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: a retrospective chart review.
     J Clin Psychiatry. 2007;68:406-9.
     PubMed     Related articles    Abstract available
     
     
     February 2007
115. GHARABAWI GM , Bossie CA, Pandina GJ, Kujawa MJ, et al
     A discussion of 2 double-blind studies comparing risperidone and quetiapine in patients with schizophrenia.
     J Clin Psychiatry. 2007;68:333.
     PubMed     Related articles   
     
     
     
116. CITROME L
     The psychopharmacology of violence with emphasis on schizophrenia, part 2: long-term treatment.
     J Clin Psychiatry. 2007;68:331-2.
     PubMed     Related articles   
     
     
     
117. SURESH KUMAR PN , Andrade C, Bhakta SG, Singh NM, et al
     Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study.
     J Clin Psychiatry. 2007;68:237-41.
     PubMed     Related articles    Abstract available
     
     
     
118. KANE JM , Meltzer HY, Carson WH Jr, McQuade RD, et al
     Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
     J Clin Psychiatry. 2007;68:213-23.
     PubMed     Related articles    Abstract available
     
     
     
119. ROSENHECK RA , Lieberman JA
     Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophrenia.
     J Clin Psychiatry. 2007;68:e05.
     PubMed     Related articles    Abstract available
     
     
     
120. LIEBERMAN JA
     Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials.
     J Clin Psychiatry. 2007;68:e04.
     PubMed     Related articles    Abstract available
     
     
     
121. KELLER ASHTON A
     Indexing of reports on aripiprazole augmentation of clozapine.
     J Clin Psychiatry. 2007;68:334-5.
     PubMed     Related articles   
     
     
     January 2007
122. MEYER JM
     Strategies for the Long-Term Treatment of Schizophrenia: Real-World Lessons From the CATIE Trial.
     J Clin Psychiatry. 2007;68 Suppl 1:28-33.
     PubMed     Related articles    Abstract available
     
     
     
123. WEIDEN PJ
     Discontinuing and Switching Antipsychotic Medications: Understanding the CATIE Schizophrenia Trial.
     J Clin Psychiatry. 2007;68 Suppl 1:12-9.
     PubMed     Related articles    Abstract available
     
     
     
124. NASRALLAH HA
     The Roles of Efficacy, Safety, and Tolerability in Antipsychotic Effectiveness: Practical Implications of the CATIE Schizophrenia Trial.
     J Clin Psychiatry. 2007;68 Suppl 1:5-11.
     PubMed     Related articles    Abstract available
     
     
     
125. CITROME L
     The psychopharmacology of violence with emphasis on schizophrenia, part 1: acute treatment.
     J Clin Psychiatry. 2007;68:163-4.
     PubMed     Related articles   
     
     
     
126. DRAKE RJ , Dunn G, Tarrier N, Bentall RP, et al
     Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England.
     J Clin Psychiatry. 2007;68:81-6.
     PubMed     Related articles    Abstract available
     
     
     
127. KAROW A , Czekalla J, Dittmann RW, Schacht A, et al
     Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia.
     J Clin Psychiatry. 2007;68:75-80.
     PubMed     Related articles    Abstract available
     
     
     
128. CHAN HY , Lin WW, Lin SK, Hwang TJ, et al
     Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in chinese patients with risperidone as an active control: a randomized trial.
     J Clin Psychiatry. 2007;68:29-36.
     PubMed     Related articles    Abstract available
     
     
     
129. ROBERT BRASHEAR H , Spivey JM
     Galantamine and QTc prolongation.
     J Clin Psychiatry. 2007;68:169.
     PubMed     Related articles   
     
     
     
130. 
     Practical applications of recent antipsychotic effectiveness data.
     J Clin Psychiatry. 2007;68:151-62.
     PubMed     Related articles   
     
     
     
131. TRAN-JOHNSON TK , Sack DA, Marcus RN, Auby P, et al
     Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.
     J Clin Psychiatry. 2007;68:111-9.
     PubMed     Related articles    Abstract available
     
     
     
132. NEWCOMER JW
     Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
     J Clin Psychiatry. 2007;68 Suppl 1:20-7.
     PubMed     Related articles    Abstract available
     
     
     
133. NASRALLAH HA
     Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
     J Clin Psychiatry. 2007;68 Suppl 1:3-4.
     PubMed     Related articles   
     
     
     
134. YOUNG AH
     Treatment of bipolar disorder with antipsychotic medication: issues shared with schizophrenia.
     J Clin Psychiatry. 2007;68 Suppl 6:24-5.
     PubMed     Related articles    Abstract available
     
     
     
135. GANGULI R
     Behavioral therapy for weight loss in patients with schizophrenia.
     J Clin Psychiatry. 2007;68 Suppl 4:19-25.
     PubMed     Related articles    Abstract available
     
     
     
136. HENNEKENS CH
     Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia.
     J Clin Psychiatry. 2007;68 Suppl 4:4-7.
     PubMed     Related articles    Abstract available
     
     
     
137. BUCKLEY PF
     Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents.
     J Clin Psychiatry. 2007;68 Suppl 6:5-9.
     PubMed     Related articles    Abstract available
     
     
     
138. GOFF DC
     Integrating general health care in private community psychiatry practice.
     J Clin Psychiatry. 2007;68 Suppl 4:49-54.
     PubMed     Related articles    Abstract available
     
     
     
139. PARKS JJ
     Implementing practice guidelines: lessons from public mental health settings.
     J Clin Psychiatry. 2007;68 Suppl 4:45-8.
     PubMed     Related articles    Abstract available
     
     
     
140. WEIDEN PJ
     Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.
     J Clin Psychiatry. 2007;68 Suppl 4:34-9.
     PubMed     Related articles    Abstract available
     
     
     
141. SERNYAK MJ
     Implementation of monitoring and management guidelines for second-generation antipsychotics.
     J Clin Psychiatry. 2007;68 Suppl 4:14-8.
     PubMed     Related articles    Abstract available
     
     
     
142. NEWCOMER JW
     Antipsychotic medications: metabolic and cardiovascular risk.
     J Clin Psychiatry. 2007;68 Suppl 4:8-13.
     PubMed     Related articles    Abstract available
     
     
     
143. HENDERSON DC
     Weight gain with atypical antipsychotics: evidence and insights.
     J Clin Psychiatry. 2007;68 Suppl 12:18-26.
     PubMed     Related articles    Abstract available
     
     
     
144. CITROME L
     The effectiveness criterion: balancing efficacy against the risks of weight gain.
     J Clin Psychiatry. 2007;68 Suppl 12:12-7.
     PubMed     Related articles    Abstract available
     
     
     
145. CITROME L
     Introduction: weighing the evidence: weight management insights for treating major mental illness.
     J Clin Psychiatry. 2007;68 Suppl 12:4.
     PubMed     Related articles   
     
     
     
146. BENCA RM
     Narcolepsy and excessive daytime sleepiness: diagnostic considerations, epidemiology, and comorbidities.
     J Clin Psychiatry. 2007;68 Suppl 13:5-8.
     PubMed     Related articles    Abstract available
     
     
     
147. WEIDEN PJ
     Understanding and addressing adherence issues in schizophrenia: from theory to practice.
     J Clin Psychiatry. 2007;68 Suppl 14:14-9.
     PubMed     Related articles    Abstract available
     
     
     
148. KEEFE RS
     Cognitive deficits in patients with schizophrenia: effects and treatment.
     J Clin Psychiatry. 2007;68 Suppl 14:8-13.
     PubMed     Related articles    Abstract available
     
     
     
149. MCEVOY JP
     The costs of schizophrenia.
     J Clin Psychiatry. 2007;68 Suppl 14:4-7.
     PubMed     Related articles    Abstract available
     
     
     
150. KANE JM
     Treatment strategies to prevent relapse and encourage remission.
     J Clin Psychiatry. 2007;68 Suppl 14:27-30.
     PubMed     Related articles    Abstract available
     
     
     
151. MEYER JM
     Antipsychotic safety and efficacy concerns.
     J Clin Psychiatry. 2007;68 Suppl 14:20-6.
     PubMed     Related articles    Abstract available
     
     
     December 2006
152. MARDER SR
     Schizophrenia: From Neuroimaging to Neuroscience.
     J Clin Psychiatry. 2006;67:2035.
     PubMed     Related articles    Abstract available
     
     
     
153. MOELLER KE , Shireman TI, Liskow BI
     Relapse rates in patients with schizophrenia receiving aripiprazole in comparison with other atypical antipsychotics.
     J Clin Psychiatry. 2006;67:1942-7.
     PubMed     Related articles    Abstract available
     
     
     
154. AKDEDE BB , Anil Yagcioglu AE, Alptekin K, Turgut TI, et al
     A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
     J Clin Psychiatry. 2006;67:1912-9.
     PubMed     Related articles    Abstract available
     
     
     
155. DE HERT M , Kalnicka D, van Winkel R, Wampers M, et al
     Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder.
     J Clin Psychiatry. 2006;67:1889-96.
     PubMed     Related articles    Abstract available
     
     
     
156. HERES S , Hamann J, Kissling W, Leucht S, et al
     Attitudes of psychiatrists toward antipsychotic depot medication.
     J Clin Psychiatry. 2006;67:1948-53.
     PubMed     Related articles    Abstract available
     
     
     November 2006
157. NEWCOMER JW
     Medical risk in patients with bipolar disorder and schizophrenia.
     J Clin Psychiatry. 2006;67:e16.
     PubMed     Related articles    Abstract available
     
     
     
158. KONDZIELLA D , Arlien-Soborg P
     Diagnostic and therapeutic challenges in narcolepsy-related psychosis.
     J Clin Psychiatry. 2006;67:1817-9.
     PubMed     Related articles   
     
     
     
159. LEUCHT S , Kane JM
     Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia.
     J Clin Psychiatry. 2006;67:1813-4.
     PubMed     Related articles   
     
     
     
160. EMSLEY R , Oosthuizen PP, Kidd M, Koen L, et al
     Remission in first-episode psychosis: predictor variables and symptom improvement patterns.
     J Clin Psychiatry. 2006;67:1707-12.
     PubMed     Related articles    Abstract available
     
     
     
161. LAMBERT M , Schimmelmann BG, Naber D, Schacht A, et al
     Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.
     J Clin Psychiatry. 2006;67:1690-7.
     PubMed     Related articles    Abstract available
     
     
     
162. WEIDEN PJ , Young AH, Buckley PF
     The art and science of switching of antipsychotic medications, part 1.
     J Clin Psychiatry. 2006;67:e15.
     PubMed     Related articles    Abstract available
     
     
     October 2006
163. TAKAHASHI H , Kamata M, Yoshida K, Ishigooka J, et al
     Switching to Olanzapine After Unsuccessful Treatment With Risperidone During the First Episode of Schizophrenia: An Open-Label Trial.
     J Clin Psychiatry. 2006;67:1577-1582.
     PubMed     Related articles    Abstract available
     
     
     
164. VALENSTEIN M , Ganoczy D, McCarthy JF, Myra Kim H, et al
     Antipsychotic Adherence Over Time Among Patients Receiving Treatment for Schizophrenia: A Retrospective Review.
     J Clin Psychiatry. 2006;67:1542-1550.
     PubMed     Related articles    Abstract available
     
     
     
165. CRESPO-FACORRO B , Perez-Iglesias R, Ramirez-Bonilla M, Martinez-Garcia O, et al
     A Practical Clinical Trial Comparing Haloperidol, Risperidone, and Olanzapine for the Acute Treatment of First-Episode Nonaffective Psychosis.
     J Clin Psychiatry. 2006;67:1511-1521.
     PubMed     Related articles    Abstract available
     
     
     
166. VAN WINKEL R , De Hert M, Van Eyck D, Hanssens L, et al
     Screening for Diabetes and Other Metabolic Abnormalities in Patients With Schizophrenia and Schizoaffective Disorder: Evaluation of Incidence and Screening Methods.
     J Clin Psychiatry. 2006;67:1493-1500.
     PubMed     Related articles    Abstract available
     
     
     
167. LIEBERMAN JA
     Neurobiology and the Natural History of Schizophrenia.
     J Clin Psychiatry. 2006;67:e14.
     PubMed     Related articles    Abstract available
     
     
     
168. GREEN MF
     Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder.
     J Clin Psychiatry. 2006;67:e12.
     PubMed     Related articles    Abstract available
     
     
     
169. LOPEZ-GARCIA P , Teresa Rodriguez J, De Castro P, Landecho I, et al
     Association between clozapine-induced agranulocytosis and HLA subtyping.
     J Clin Psychiatry. 2006;67:1652-3.
     PubMed     Related articles   
     
     
     
170. BERNER MM , Hagen M, Kriston L
     A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed.
     J Clin Psychiatry. 2006;67:1649-50.
     PubMed     Related articles   
     
     
     
171. HARVEY PD
     Cognitive and functional effects of atypical antipsychotic medications.
     J Clin Psychiatry. 2006;67:e13.
     PubMed     Related articles    Abstract available
     
     
     September 2006
172. JUNG DU , Conley RR, Kelly DL, Kim DW, et al
     Prevalence of Bone Mineral Density Loss in Korean Patients With Schizophrenia: A Cross-Sectional Study.
     J Clin Psychiatry. 2006;67:1391-1396.
     PubMed     Related articles    Abstract available
     
     
     
173. WEISSMAN EM , Zhu CW, Schooler NR, Goetz RR, et al
     Lipid Monitoring in Patients With Schizophrenia Prescribed Second-Generation Antipsychotics.
     J Clin Psychiatry. 2006;67:1323-1326.
     PubMed     Related articles    Abstract available
     
     
     
174. TAMMINGA CA
     The Neurobiology of Cognition in Schizophrenia.
     J Clin Psychiatry. 2006;67:e11.
     PubMed     Related articles    Abstract available
     
     
     
175. JARSKOG LF , Lieberman JA
     Neuroprotection in Schizophrenia.
     J Clin Psychiatry. 2006;67:e09.
     PubMed     Related articles    Abstract available
     
     
     
176. GREEN AI , Brown ES
     Comorbid Schizophrenia and Substance Abuse.
     J Clin Psychiatry. 2006;67:e08.
     PubMed     Related articles    Abstract available
     
     
     
177. MARKHAM-ABEDI C , de Leon J
     Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report.
     J Clin Psychiatry. 2006;67:1473-4.
     PubMed     Related articles   
     
     
     
178. MAGO R , Anolik R, Johnson RA, Kunkel EJ, et al
     Recurrent priapism associated with use of aripiprazole.
     J Clin Psychiatry. 2006;67:1471-2.
     PubMed     Related articles   
     
     
     
179. LIN CY , Wu PL, Pariante CM, Su KP, et al
     A crossover study of prolactin changes associated with risperidone and olanzapine.
     J Clin Psychiatry. 2006;67:1470.
     PubMed     Related articles   
     
     
     
180. KELLY DL , Dixon LB, Kreyenbuhl JA, Medoff D, et al
     Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.
     J Clin Psychiatry. 2006;67:1404-11.
     PubMed     Related articles    Abstract available
     
     
     
181. PHILLIPS GA , Van Brunt DL, Roychowdhury SM, Xu W, et al
     The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone.
     J Clin Psychiatry. 2006;67:1397-403.
     PubMed     Related articles    Abstract available
     
     
     
182. TOPRAC MG , Dennehy EB, Carmody TJ, Crismon ML, et al
     Implementation of the Texas Medication Algorithm Project patient and family education program.
     J Clin Psychiatry. 2006;67:1362-72.
     PubMed     Related articles    Abstract available
     
     
     August 2006
183. VINER MW , Matuszak JM, Knight LJ
     Initial dosing strategies for long-acting injectable risperidone.
     J Clin Psychiatry. 2006;67:1310-1.
     PubMed     Related articles   
     
     
     
184. LIN SK , Chen CK
     Reversal of antipsychotic-induced hyperprolactinemia, weight gain, and dyslipidemia by aripiprazole: A case report.
     J Clin Psychiatry. 2006;67:1307.
     PubMed     Related articles   
     
     
     
185. MALASPINA D
     Schizophrenia: A Neurodevelopmental or a Neurodegenerative Disorder.
     J Clin Psychiatry. 2006;67:e07.
     PubMed     Related articles    Abstract available
     
     
     
186. HARVEY PD
     Outcomes to Monitor When Treating Bipolar Disorder or Schizophrenia.
     J Clin Psychiatry. 2006;67:e06.
     PubMed     Related articles    Abstract available
     
     
     July 2006
187. MARDER SR
     Initiatives to promote the discovery of drugs to improve cognitive function in severe mental illness.
     J Clin Psychiatry. 2006;67:e03.
     PubMed     Related articles    Abstract available
     
     
     January 2006
188. CAINE ED
     Clinical perspectives on atypical antipsychotics for treatment of agitation.
     J Clin Psychiatry. 2006;67 Suppl 10:22-31.
     PubMed     Related articles    Abstract available
     
     
     
189. SACHS GS
     A review of agitation in mental illness: burden of illness and underlying pathology.
     J Clin Psychiatry. 2006;67 Suppl 10:5-12.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: